Paxlovid

[Bill the Cat]

I have been getting messages in my Pharmacy portal for Paxlovid, an anti-viral that they say is helpful in treating COVID-19 infections. Is it really that successful, and if so, why is the State of Emergency still going on?

[mossrose]

I’ve heard it’s good. The problem now is that in the early days the vax was The Thing, and doctors and pharmacists were told not to prescribe or dispense Paxlovid. And we know it’s all about control of the populace.

And money for the vax.

[One Bad Pig]

I'm still not allowed to go to the office because I didn't get the jab.

[Cow Poke]

Hmmmmm

[Bill the Cat]

I'm still not allowed to go to the office because I didn't get the jab.

That's just stupid.

[Cow Poke]

I'm still not allowed to go to the office because I didn't get the jab.

The Republican Candidate for POTUS - whoever that might be - should campaign on Trump's promise to reinstate every military member who was booted out because of the vax requirement with BACKPAY.

[Bill the Cat]

The Republican Candidate for POTUS - whoever that might be - should campaign on Trump's promise to reinstate every military member who was booted out because of the vax requirement with BACKPAY.

Or upgrade their discharge to Honorable and offer them a Federal job

[Cow Poke]

Or upgrade their discharge to Honorable and offer them a Federal job

Or that! Somehow - recognize them and fairly compensate them for the contempt shown them by this administration.

[mossrose]

I'm still not allowed to go to the office because I didn't get the jab.

[rogue06]

I have been getting messages in my Pharmacy portal for Paxlovid, an anti-viral that they say is helpful in treating COVID-19 infections. Is it really that successful, and if so, why is the State of Emergency still going on?

13 Things To Know About Paxlovid, the Latest COVID-19 Pill

The issue seems to be what's called "Covid Rebound" and the suggestion that those who took Paxlovid have an increased chance of testing positive for it not long after recovering (the above brings that up in #11).

[Juvenal]

That's just stupid.

I wouldn't go that far, but he should definitely get the jab.

[Bill the Cat]

I wouldn't go that far, but he should definitely get the jab.

It's positively pointless at this point

[Juvenal]

It's positively pointless at this point

US renews push for COVID boosters as data show they protect
.

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday.

Updated boosters rolled out by Pfizer and rival Moderna in September have been a hard sell for vaccine-weary Americans. Only about 13% of U.S. adults so far have gotten a “bivalent” shot that targets the omicron strain as well as the original coronavirus. On Tuesday, White House officials announced a renewed push for more Americans to get the latest shots.

In the first look at the new shots’ real-world effectiveness, the Centers for Disease Control and Prevention tracked people with coronavirus-like symptoms who sought testing at drugstores around the country between September and early November. Researchers compared the vaccination status of those who wound up having COVID-19 with those who didn’t.

The new omicron-targeting booster added 30% to 56% protection against symptomatic infection, depending on how many prior vaccinations someone had, how long ago and their age, the CDC concluded.

People getting the greatest benefit are those who’d never had a prior booster, just two doses of the original COVID-19 vaccine at least eight months earlier, said CDC’s Dr. Ruth Link-Gelles, who led the study.

But even people who got a summertime booster of the original vaccine before seeking the new fall formula were 30% to 40% more protected than if they’d skipped this latest shot, she said.

“We think about it as the additional benefit or incremental benefit of getting one more dose, and in this case that one more dose is a bivalent,” Link-Gelles said.

The updated boosters target the BA.5 omicron strain that until recently was the most common type. The original COVID-19 vaccines have offered strong protection against severe disease and death no matter the variant, but protection against mild infection has proved temporary. CDC’s analysis tracked only the first few months of the new boosters’ use so it’s too early to know how long the added protection against symptomatic infection lasts.

...

[Bill the Cat]

US renews push for COVID boosters as data show they protect
.

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday.

Updated boosters rolled out by Pfizer and rival Moderna in September have been a hard sell for vaccine-weary Americans. Only about 13% of U.S. adults so far have gotten a “bivalent” shot that targets the omicron strain as well as the original coronavirus. On Tuesday, White House officials announced a renewed push for more Americans to get the latest shots.

In the first look at the new shots’ real-world effectiveness, the Centers for Disease Control and Prevention tracked people with coronavirus-like symptoms who sought testing at drugstores around the country between September and early November. Researchers compared the vaccination status of those who wound up having COVID-19 with those who didn’t.

The new omicron-targeting booster added 30% to 56% protection against symptomatic infection, depending on how many prior vaccinations someone had, how long ago and their age, the CDC concluded.

People getting the greatest benefit are those who’d never had a prior booster, just two doses of the original COVID-19 vaccine at least eight months earlier, said CDC’s Dr. Ruth Link-Gelles, who led the study.

But even people who got a summertime booster of the original vaccine before seeking the new fall formula were 30% to 40% more protected than if they’d skipped this latest shot, she said.

“We think about it as the additional benefit or incremental benefit of getting one more dose, and in this case that one more dose is a bivalent,” Link-Gelles said.

The updated boosters target the BA.5 omicron strain that until recently was the most common type. The original COVID-19 vaccines have offered strong protection against severe disease and death no matter the variant, but protection against mild infection has proved temporary. CDC’s analysis tracked only the first few months of the new boosters’ use so it’s too early to know how long the added protection against symptomatic infection lasts.

...

Heard that song and dance before. Still not convincing. If you are afraid though, by all means, have at it.

[One Bad Pig]

US renews push for COVID boosters as data show they protect
.

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday.

Updated boosters rolled out by Pfizer and rival Moderna in September have been a hard sell for vaccine-weary Americans. Only about 13% of U.S. adults so far have gotten a “bivalent” shot that targets the omicron strain as well as the original coronavirus. On Tuesday, White House officials announced a renewed push for more Americans to get the latest shots.

In the first look at the new shots’ real-world effectiveness, the Centers for Disease Control and Prevention tracked people with coronavirus-like symptoms who sought testing at drugstores around the country between September and early November. Researchers compared the vaccination status of those who wound up having COVID-19 with those who didn’t.

The new omicron-targeting booster added 30% to 56% protection against symptomatic infection, depending on how many prior vaccinations someone had, how long ago and their age, the CDC concluded.

People getting the greatest benefit are those who’d never had a prior booster, just two doses of the original COVID-19 vaccine at least eight months earlier, said CDC’s Dr. Ruth Link-Gelles, who led the study.

But even people who got a summertime booster of the original vaccine before seeking the new fall formula were 30% to 40% more protected than if they’d skipped this latest shot, she said.

“We think about it as the additional benefit or incremental benefit of getting one more dose, and in this case that one more dose is a bivalent,” Link-Gelles said.

The updated boosters target the BA.5 omicron strain that until recently was the most common type. The original COVID-19 vaccines have offered strong protection against severe disease and death no matter the variant, but protection against mild infection has proved temporary. CDC’s analysis tracked only the first few months of the new boosters’ use so it’s too early to know how long the added protection against symptomatic infection lasts.

...

At this point, I've had Covid twice. The first time, my fever lasted 3 days. The second time, I had about a half-degree fever and felt bad for an evening; worked the next day (from home). The second time, everybody in the house got it, except for my wife, who'd already had Covid twice (second time for her was also rather mild). I think I'll pass, thanks.